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Background: Benign esophageal diseases constitute a common group of
disorders that are generally managed with medical therapy or surgery
designed to improve foregut function. A small subset of patients, however,
has advanced disease that requires esophageal replacement to achieve
symptomatic relief. Patients and methods: One hundred four patients with
benign esophageal disease who underwent esophageal reconstruction over
a 21-year period (1975 to 1996) were reviewed retrospectively. Dysphagia
was the major symptom driving surgery in 80% of the patients. Colon was
used to reconstruct the esophagus in 85 patients; stomach, in 10 patients;
and jejunum, in 9 patients. Forty-two patients who had lived with their
reconstruction for 1 year or more answered a postoperative questionnaire
concerning their long-term functional outcome. Results: In the 104 patients,
the primary underlying abnormality leading to esophageal replacement was
end-stage gastroesophageal reflux (37 patients), an advanced motility
disorder (37 patients), traumatic, iatrogenic or spontaneous perforation
(15 patients), corrosive injury (8 patients), congenital abnormality (6
patients), or extensive leiomyoma (1 patient). Ninety-eight percent of
patients reported that the operation had cured or improved the symptom
driving surgery. Ninety-three percent were satisfied with the outcome of the
operation. The overall hospital mortality rate was 2%, and the median
hospital stay was 17 days. Graft necrosis occurred in 3% of patients, and
anastomotic leak occurred in 6% of patients (or 2% of the total number of
anastomoses). Conclusions: Esophageal replacement for benign disease can
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be accomplished with a low mortality rate and a marked improvement in
alimentation. Reconstruction restores the pleasure of eating and is viewed
by the patient to be highly successful. (J Thorac Cardiovasc Surg 1998;115:
1241-9)
Benign esophageal diseases constitute some of themost common disorders affecting the gastroin-
testinal tract. In most cases, the symptoms experi-
enced by patients with esophageal disease are mi-
nor, intermittent, and easily controllable with
medications or lifestyle modifications. A subset of
patients with more advanced disease may be re-
ferred for surgical therapy designed to improve
foregut function or to correct anatomic abnormali-
ties. There remains a group of patients, however,
with end-stage esophageal disease in whom the
magnitude of esophageal dysfunction is such that
esophageal resection with replacement remains the
only alternative.
This study reports a 21-year experience with esoph-
ageal replacement for end-stage, benign disease, with a
specific focus on the conditions that lead to esophageal
replacement, the effectiveness of relieving the primary
symptom driving the replacement, the morbidity and
mortality rates of replacement, and the patient’s func-
tional status after the replacement.
Studied population and methods
Patients who had undergone esophageal resection and
reconstruction for benign disease by the authors over a
21-year period (1975 to 1996) were reviewed retrospec-
tively. Patients in whom esophagectomy was performed
for severe dysplasia were excluded from the analysis. The
studied group consisted of 104 patients, 59 of whom were
male and 45 of whom were female, ranging in age from 6
to 79 years with a median age of 44 years. Eighty-eight
percent of patients had at least one prior esophageal
operation with a median of two and a maximum of 12
operations. The most common previous procedure was an
ineffective antireflux operation.
Dysphagia was the major symptom driving esophageal
resection and replacement in 80% of patients. Other
symptoms necessitating esophagectomy were repetitive
aspiration (2%) and acute hemorrhage (1%). In the
remaining patients, the procedure was performed to con-
trol acute or chronic sepsis (13%) or to reestablish
gastrointestinal continuity after a previously failed recon-
struction (4%). Most patients had a litany of additional
symptoms, all of which were secondary to foregut dysfunc-
tion (Table I).
The functional status of the foregut was routinely
evaluated before resection and reconstruction in an effort
to determine the cause of the patient’s driving symptom.
Diagnostic modalities included video upper gastrointesti-
nal barium contrast study, esophagogastroduodenoscopy,
stationary and/or ambulatory esophageal manometry, 24-
hour esophageal and/or gastric pH monitoring, and scin-
tigraphic gastric emptying scans. On the basis of these
studies, the patients were classified as to the underlying
disease process causing functional failure of the foregut.
Two conditions were identified as being problematic to
the surgeon treating end-stage esophageal diseases and
require further comment. The first relates to the defini-
tion of esophageal body failure. In our patient population,
propulsive failure was defined by the presence of 40% or
more simultaneous waveforms in the distal two thirds of
the esophagus associated with contraction amplitudes
below the 5th percentile of normals (,25 mm Hg).1 The
second problematic area relates to the definition of an
undilatable esophageal stricture. Our preference for
esophageal dilatation in patients with advanced disease
and a previous history of repetitive dilatations was to use
the Eder-Puestow or Savary dilators (New Eder Corpora-
tion, Wood Dale, Ill.) under fluoroscopic control after the
patient had been given a general anesthetic in the oper-
ating room. If the stricture was successfully dilated, the
patient was instructed in the technique of home dilatation,
and the response to dilatation was assessed. Esophageal
function studies were performed when the response to
dilatation was optimal. Patients with esophageal strictures
were considered for esophageal resection and replacement
when dilatation was not possible or, if possible, was unable to
provide relief from dysphagia or the relief was short-lived.
The latter was usually associated with esophageal body
propulsive failure.
Colon was used initially to reconstruct the esophagus in
85 patients; stomach was used in 10 patients, and jejunum
was used in 9 patients. In five patients undergoing recon-
struction with colon, the esophagus was removed with a
vagal sparing technique (Fig. 1). This was accomplished by
dividing the esophagus in the neck and at the gastroesoph-
ageal junction in the abdomen, sparing the vagal nerves.
The latter was achieved by performing a highly selective
vagotomy along the proximal lesser curvature and dividing
the stomach just below the gastroesophageal junction.
The isolated esophagus was removed by passing a vein
stripper up through the esophagus from the abdomen,
securing it to the distal portion of the divided cervical
esophagus, and invaginating the esophagus as it is pulled
out through the esophageal hiatus.2 The vagal nerves were
sheared off as the muscular wall turned in during the
invagination process. The remaining posterior mediastinal
tunnel was progressively dilated with a 90 ml Foley
catheter balloon to create an adequate passageway for the
colon interposition graft. One patient in whom ischemic
necrosis developed after a reverse colon interposition was
referred for treatment with a blind remnant of the re-
versed colon anastomosed to the stomach. Her condition
was managed by dividing the middle colic artery supplying
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and tethering the blind segment, placing the blind seg-
ment substernally, reestablishing the blood supply by
anastomosing the middle colic vessels to the left internal
thoracic vessels, and restoring gastrointestinal continuity
by an esophagocolonic anastomosis.
Of the 104 patients, seven required an additional pro-
cedure to achieve a good functional outcome. In five
patients, the colon graft was tortuous and redundant, or
there was delayed emptying of a retained, denervated
stomach. The revision in these patients consisted of
tailoring or resecting a segment of the colon graft, resect-
ing the proximal stomach with reanastomosis of the
antrum to the colon or, when length was insufficient,
placing a jejunal interposition between the colon and the
gastric antrum (Fig. 2). The sixth patient had an ischemic
colon that was revised with a gastric pull-up; the seventh
patient had an ischemic gastric pull-up that was revised
with a free jejunal graft. Of the 104 patients undergoing
esophageal replacement, 42 who had lived with their
reconstruction for 1 year or more were contacted by
telephone to answer a postoperative questionnaire. The
questionnaire asked specifically about the time required
after hospital discharge for the patient to achieve a full
functional recovery, the patient’s current ability to ingest a
meal, annoyances the patient was presently experiencing
related to alimentation, and the overall patient satisfac-
tion with the outcome of their operation (Table II). The
median follow-up was 26 months with a follow-up interval
of 1 to 2 years for 20 patients, 2 to 4 years for 16 patients,
and more than 4 years for 6 patients.
Results
Conditions leading to esophageal replacement.
The benign diseases leading to esophageal replace-
ment are listed in Table III. End-stage gastroesoph-
ageal reflux disease and advanced esophageal mo-
tility disorders were the most common underlying
conditions. In some situations, the disease advanced
despite appropriate medical or surgical therapy. In
other situations, an inappropriate or poorly admin-
istered therapy contributed to the deterioration in
esophageal function. Iatrogenic esophageal injuries
occurred from endoscopic or surgical procedures on
the esophagus or inadvertent injury to the esopha-
gus by operation on adjacent organs. Examples of
the latter were mediastinoscopy, coarctation repair,
vagotomy, and spinal surgery.
Effectiveness of esophageal replacement in reliev-
ing the primary symptom driving surgery. Ninety-
eight percent of the patients judged that their
operation had a positive effect on the primary
symptom or condition driving the operation. Specif-
ically, 73% of the patients were improved, and 25%
of the patients were cured of their preoperative
complaints by esophageal replacement. Ninety-
three percent of the patients were satisfied with the
overall outcome of the operation. Ninety-five per-
cent of the patients stated that, if faced with the
decision again, they would make the choice to
undergo the procedure.
Table I. Symptoms of end-stage esophageal disease
(n 5 104)
Symptom Percent
Dysphagia 90
Regurgitation 57
Heartburn 52
Weight loss 32
Chest pain 25
Epigastric pain 22
Vomiting 20
Coughing 18
Nausea 18
Choking 9
Voice change 7
Diarrhea 3
Odynophagia 2
Anorexia 1
Bloating 1
Fig. 1. Schematic drawing of a vagal sparing esophagec-
tomy with colon interposition. This reconstruction ap-
pears to give the best postoperative function.
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Morbidity and mortality rates of esophageal re-
placement. Median hospital stay was 17 days, with a
range of 7 to 216 days. Two patients died while in
the hospital, resulting in a mortality rate of 2%.
Both died of sepsis with multiple organ failure.
Graft necrosis occurred in three patients (3%), two
with colon interpositions and one with a gastric
pull-up. One necrotic colon graft resulted in a
hospital death; one necrotic colon graft was re-
moved with subsequent reconstruction by the use of
a gastric pull-up, and one ischemic gastric pull-up
was removed and later replaced with a free jejunal
interposition. A leak at one of the anastomotic sites
occurred in six patients (6%), or 2% of anastomoses.
The most commonly affected anastomosis was the
esophagocolostomy (Table IV). Thirty percent of
patients undergoing gastric pull-up required postop-
erative dilatation, although only 5% of patients with
colon interposition did. Only one patient, with a
gastric pull-up, experienced persistent dysphagia
requiring intermittent dilatations.
Functional status after esophageal replacement.
From the perspective of the 42 patients who
responded to the questionnaire, it took a median
of 2 weeks after discharge to achieve full recovery,
with a range of 1 to 96 weeks. Overall, 83% of
patients reported enjoying three meals a day
without difficulty, although only 15% and 2% were
limited to two or one meals, respectively. Fifty-
three percent of the patients had the capacity to
eat a steak dinner at one sitting; 32% of the
patients were limited to the size of a first-class
airline meal and 15% to an airline snack (Table
V). Sixty-nine percent of patients had the pleasure
of an unrestricted diet. The process of ingestion
was slower after esophageal replacement because
62% of the patients were the last to finish in a
group meal. Minor inconveniences in the patient’s
ability to ingest were the requirement for liquid in
32% of the patients, a sensation of slow transit in
25% of the patients, and choking in 2% of the
patients. The number of patients evaluated after a
gastric pull-up or jejunal interposition was too
Table II. Categories assessed by questionnaire
Recovery Ingestion
Annoyances
related to
alimentation
Overall
satisfaction
Time to full
recovery
Number of
meals/day
Dumping Relief of
symptoms
Meal capacity Nausea Outcome of
surgery
Diet restraints Bloating Risk/benefit
assessment
Last to finish Frequent stools
Early satiety Nocturnal
regurgitation
Require liquids Gurgling
Slow transit Bad breath
Odynophagia
Choking
Fig. 2. Schematic drawing of a composite graft used to
salvage patients who have an existing nonfunctional colon
interposition. In most situations the size of the retained
proximal colon was reduced by a coloplasty.
Table III. Benign esophageal conditions leading to
replacement
Diagnosis
No. of
patients
End-stage GERD 37
Undilatable stricture 25
Other 12
Advanced motility disorder 37
Traumatic or iatrogenic injury or spontaneous
perforation
15
Corrosive injury 8
Congenital abnormality 6
Extensive leiomyoma 1
GERD, Gastroesophageal reflux disease.
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small to justify a comparative analysis with colon
interposition. Some patients gained and others
lost weight after the operation. Overall the me-
dian change in weight was a gain of 10 pounds,
with a range of 253 to 170 pounds.
Annoyances related to alimentation that occa-
sionally occurs after esophageal replacement and
reconstruction of the foregut are shown in Table VI.
With the exception of gurgling and bad breath and
for some patients nocturnal regurgitation, these
complaints were present before surgery and per-
sisted after reconstruction. The most bothersome
was nocturnal regurgitation and was alleviated by
elevation of the head of the bed. All annoyances
tended to abate with time.
Discussion
The most common abnormalities leading to
esophageal replacement are end-stage gastroesoph-
ageal reflux disease and advanced motility disorders.
Of all the benign conditions potentially requiring
esophageal replacement, these two are the most
problematic in terms of the decision to abandon
medical therapy or less extensive surgical therapy
and proceed with esophagectomy. Because previous
surgical therapy may have contributed to the prob-
lem, both patient and physician may be reluctant
about further surgical intervention. Each additional
non-extirpative procedure, however, such as a dila-
tation of a stricture, pneumatic dilatation for acha-
lasia, fundoplication, or myotomy has the potential
to cause further tissue damage with additional loss
of function.
Similarly, each successive operative mobilization
reduces the blood supply to the esophagus, with the
possibility of ischemic necrosis, and puts the vagus
nerves in jeopardy, with the possibility of altered
foregut motility. Experience has taught us that a
successful outcome after three previously failed oper-
ations about the lower esophageal sphincter is un-
likely. The need for a fourth procedure is usually an
indication for esophageal resection with replacement.
A subject of considerable controversy is the ap-
propriate choice of an esophageal substitute. We
have opted to use the colon, when of suitable
quality, in the patient with benign disease who has a
long life expectancy. Although the number of pa-
tients in our series who have undergone esophageal
replacement with stomach or jejunum is too small to
justify a meaningful comparative analysis of func-
tional outcomes versus the colon interposition
group, we based our decision to use colon in most of
the patients on several important considerations.
A gastric advancement, when present for an ex-
tended time period, is prone to the development of
several complications. Although technically easier
to perform, the gastric advancement is frequently
associated with symptoms from duodenogastric re-
flux and rapid gastric emptying in the upright posi-
tion.3 Most patients experience symptoms during or
shortly after eating, the most common being a
postprandial pressure sensation and early satiety,
probably related to the loss of the gastric reservoir.
The late appearance of proximal esophagitis, ste-
nosis, or Barrett’s esophagus is common with an
esophagogastric anastomosis made within the
chest.4 For this reason alone, an intrathoracic
esophagogastrostomy should be abandoned. We vir-
tually never perform an Ivor Lewis–type esophagec-
tomy with an intrathoracic esophagogastrostomy.
Although there is general acceptance of the concept
that an esophagogastric anastomosis in the neck
results in less postoperative esophagitis and stricture
formation than one performed within the chest,
reflux esophagitis after a cervical anastomosis does
occur. Patients undergoing a cervical esophagogas-
Table IV. Anastomotic leaks after primary reconstruction*
Site
Total
(no.)
Leak
(no.) %
Postoperative
day Outcome
Esophagocolonic 85 3 3.5 4, 12, 28 Healed conservatively
Died (sepsis)
Healed conservatively with stenosis,
reanastomosed successfully at 27 mo.
Cologastric 84† 1 1.2 7 Healed conservatively
Esophagogastric 10 2 20 10, 11 Healed conservatively
Healed conservatively
No leaks occurred in 84 colocolonic, 9 esophagojejunal, or 9 jejunogastric anastomoses.
*Seven patients underwent a subsequent remedial procedure, one of whom experienced the development of a leak at the anastomosis between a free jejunal
graft and the stomach.
†One patient was referred after a failed colon interposition with an intact cologastric anastomosis.
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trostomy for benign disease can experience prob-
lems associated with the anastomosis in year 4 or 5
after the operation. This may be severe enough to
require anastomotic revision and is due to continued
acid production by the stomach after a pull-up
procedure, despite having been vagotomized.5 As a
result, the positioning of gastric epithelium in juxta-
position to squamous esophageal mucosa predis-
poses the patient to the development of esophagitis,
stricture, or columnar metaplasia within the esoph-
ageal remnant. A recent series from Japan revealed
reflux esophagitis in 44% of patients and Barrett’s
metaplasia in 12% of patients, followed more than 2
years after a cervical esophagogastrostomy.6 In con-
trast, the esophageal mucosa in patients with colonic
interpositions appears to undergo little if any histo-
logic changes.7
Orringer and Stirling8 have reported on 87 pa-
tients who underwent esophageal replacement by
use of the stomach for benign diseases. Fifty-four of
the patients (67%) required immediate postopera-
tive dilatation and 13 of them (15%) had persistent
dysphagia requiring home dilatation.
Similarly, we had a 30% incidence of postopera-
tive dilatations after esophagogastrostomy. This
early postoperative stricturing may well relate to
ischemia of the stomach at the site of anastomosis.
In comparison, only 5% of our patients with a
esophagocolonic anastomosis required immediate
dilatation, and none had persistent dysphagia re-
quiring home dilatation.
We acknowledge that complications may also
develop in colonic interpositions, although we be-
lieve that, with meticulous attention to operative
detail, the incidence if such problems occur can be
minimized. Six of our patients initially undergoing a
colon interposition had to undergo a subsequent
revision, the majority for graft redundancy or de-
layed emptying secondary to a retained, denervated
stomach. As experience was gained and these com-
plications were recognized, modifications in our
surgical technique were made to circumvent such
problems. We now are diligent about removing all
redundancy and tortuosity from the colonic graft
before performing the cologastric anastomosis. Be-
cause many of the problems ascribed to colon
interposition are merely the results of poor gastric
emptying, we now perform a two-thirds proximal
gastrectomy whenever a colon is interposed to a
denervated stomach. The remaining distal third of
the stomach is anastomosed end to end to the colon
graft. This gives a better result in that the colonic
interposition functions as a contracting reservoir for
the retained antrum, which continues with its own
innate contractions at 3 cycles per minute, thereby
maintaining its pump function.
The most common symptom after esophageal
replacement with an interposed colon is the sensa-
tion of fullness or pressure after meals. This com-
plaint is more prone to occur early after surgery and
is exaggerated by over-ingestion of food.
This reflects the limited reservoir capacity of the
colon and the fact that further stretch is not toler-
ated without discomfort. The complaint is less likely
to occur if the colon is anastomosed to an inner-
vated and intact stomach, as occurs with a vagal
sparing esophagectomy.
Fullness after meals is often interpreted incor-
rectly as dysphagia. True dysphagia, however, is
uncommon after colon interposition and, when it
occurs, is usually due to an anastomotic stricture or
redundancy of the graft. Over time, the amount of
food that can be ingested at one sitting by a patient
with a colon interposition increases, such that a
socially acceptable meal can be enjoyed without
discomfort. A key benefit of the colon is that the
longer it is interposed, the better it seems to func-
tion and the more satisfied the patient becomes.
Consequently, for patients with benign disease we
Table V. Comparison between types of interposition
and ability to ingest
Assessment
Percentage
Colon
(n 5 31)
Stomach
(n 5 5)
Jejunum
(n 5 6)
Able to take three
meals/day
87 80 67
Able to eat steak dinner 58 40 33
Normal transit 81 60 50
Free of satiety 45 20 17
Table VI. Annoyances related to alimentation that
occasionally occur after esophageal replacement (n
5 42)
Complaints Percent
Nausea 24
Bad breath 22
Nocturnal regurgitation 20
Bloating 20
Frequent stools 19
Dumping 13
Gurgling 4
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prefer a colon interposition to obviate the late
problems associated with esophagogastrostomy.
In our experience, the most satisfactory esopha-
geal replacement is achieved when a vagal sparing
esophagectomy can be performed. Many of the
annoyances that occur after esophageal replacement
are due to the concomitant vagotomy and the loss of
parasympathetic modulation of foregut function. By
sparing the vagus nerves, the colon is anastomosed
to a fully innervated stomach and distal gastrointes-
tinal tract. Of course, this procedure is only appli-
cable when the vagi have not been previously com-
promised and the patient does not otherwise have
gastroparesis. Patients with achalasia, who have
enlarged blood vessels supplying their esophagus, or
those who have scarring from previous esophageal
or mediastinal surgery require a thoracotomy to
mobilize the intrathoracic esophagus along with the
vagal plexus on its surface before its stripping.
We have experience with vagal-sparing esopha-
gectomy and colon interposition in several recent
patients. On the basis of our early experience with
the procedure and its theoretic advantages, we
believe it to be the operation of choice for esopha-
geal reconstruction when it can be technically ac-
complished, the patient is physiologically fit, and
long-term esophageal function is sought.
In summary, our preferred method of esophageal
replacement after esophagectomy for benign dis-
ease, in patients fit to undergo such a procedure, is
a vagal sparing esophagectomy with colon interpo-
sition, the colon being anastomosed to the intact
stomach. If the vagus nerves have been previously
compromised or cannot be preserved, a proximal
two-thirds gastrectomy is performed. If the colon is
unsuitable as an esophageal substitute or the patient
is elderly or infirm, the stomach is used. Only if both
of these organs are unsuitable or unavailable would
consideration be given to the use of the jejunum,
either as a transposition or as a free graft.
Summary
The observation that esophageal resection and
reconstruction for benign disease can be performed
with only a 2% mortality rate, minimal morbidity,
and a 98% incidence of improvement in the main
symptoms driving surgery is encouraging news to
patients who are crippled from the various manifes-
tations of advanced esophageal disease. Patients
referred to our center for esophageal reconstruction
had universally had unsuccessful attempts at more
conservative approaches elsewhere, a fact that fur-
ther supports the decision to proceed with resection
in cases of advanced benign disease. The continua-
tion of slow, anxious, and socially restricted alimen-
tation or the maintenance of nutrition by enteral or
parenteral means is unnecessary. The patient should
be referred to a unit skilled in evaluating foregut
function, performing esophageal replacement sur-
gery, and caring for patients in the perioperative
period. In our experience, the colon, when available,
is the preferred conduit for esophageal replacement
over the long term. Esophageal replacement, how-
ever, does not restore alimentation to the level
experienced by an individual with a normal esoph-
agus. Despite the fact that some subtle preoperative
symptoms of foregut dysfunction may persist after
surgery, the overall outcome is judged to be satis-
factory. Indeed, patients can reenter society and live
a normal and fulfilled life after remedial surgery.
Esophageal reconstruction restores the pleasure of
eating and dramatically improves the quality of life for
patients with end-stage, benign esophageal disease.
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Discussion
Dr. Alex G. Little (Las Vegas, Nev.). There is a folk
aphorism, “If it ain’t broke, don’t fix it”; but the corollary
is that, if it is broke, you should fix it. You cannot repair
it simply by changing from one broken entity to another;
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and, despite the instinct to salvage the esophagus, it is not
going to function if the patient is not going to be able to
use it even if it is still there. It is better off being replaced.
I would suggest that is the important global message of
this paper.
Just a few questions. First, focusing on the patients with
reflux who make up the predominant population, could
you make any statements about the cause of failure of the
first operation? Was it typically a failure actually of
diagnosis so that people are having inappropriate opera-
tions or were there technical errors? If so, could you
pinpoint the most common errors so that we can get to
prevention of reoperations rather than technique?
Dr. Watson. The majority of patients who were referred
to us with failures after antireflux surgery had experienced
this failure because of technical problems. The most
common type of problem was slippage of the wrap about
the proximal stomach rather than about the distal esoph-
agus; the second most common problem was herniation of
the wrap up into the chest. We have found that many of
these people had a short esophagus, and we think that
may have been the cause.
Dr. Little. Do you think closure of the hiatus was
commonly done initially? That is, one of the things I see
from time to time is patients who seem to have had a
reasonably well-constructed wrap, but nobody bothered to
close the hiatus.
Dr. Watson. I cannot comment on that with exact
numbers. Again, I would say that the short esophagus was
a problem, and it was not recognized.
Dr. Little. My second question related to reflux has to
do with patients who are being reoperated on. Can you
make a decision about resection versus a redo antireflux
procedure before surgery, or is that a decision that is
made during the operation? My own experience would be
that occasionally, at least, it is necessary to make that
decision intraoperatively. What operative approach do
you choose when you are reoperating? I tend to prefer the
thoracic approach because it leaves all the options open,
both reconstruction and resection. An abdominal or even
laparoscopic approach can result in a situation that limits
the surgeon.
Dr. Watson. Whether we make the decision to redo an
antireflux procedure or to resect the esophagus depends
on several factors. First of all, it depends on the underly-
ing status of the esophageal body; if the esophageal body
has demonstrated propulsive failure and we believe that
an antireflux operation is likely not to correct any under-
lying dysphagia, then that would certainly be an indication
to proceed with resection. We have also followed the rule
that, if a person has had three previously failed antireflux
operations, further attempts are unwarranted and we
would consider esophageal replacement.
Our approach to redo antireflux surgery has been
through a left transthoracic approach. This allows us to
approach the hiatus through virgin tissues. It allows us
to fully mobilize the esophagus, especially when esoph-
ageal length is a problem, and allows us to more easily
perform an esophageal lengthening procedure if that is
necessary. On occasion, though, the decision is made
intraoperatively, because of damage to the tissues with
repeat dissection, that an esophageal resection will be
necessary.
Dr. Little. My final question has to do with the choice of
replacement organ; I am a bit struck by your enthusiasm
for the long-segment colon interposition. I am sure you
are aware that has not been a universal experience. For
example, at the University of Chicago, a review of a large
number of these patients documented that up to one third
of them needed some type of reoperation related directly
to the colon itself. Therefore many of us have gone to a
more selective approach where the colon is preferred for
what you might call a short segment interposition, that is,
two thirds of the esophagus is still anatomically and
functionally available. Then you can do something
through the left side of the chest with a short segment
colon or even jejunum that is a reasonable procedure. In
contrast I and others have found better functional results
from stomach, tubed stomach, when reconstruction is in
the neck. I guess I am asking if you think your experience
is unique or will be able to be duplicated. In other words,
I am concerned about routine use of the colon for
anastomosis in the neck.
Dr. Watson. A colon interposition is certainly a more
technically demanding operation than are gastric pull-ups.
We believe that, especially with the availability of vagal
sparing transhiatal techniques, a long-segment colon gives
the best long-term outcome. It also avoids some of the
problems associated with an intrathoracic anastomosis, as
you are all aware, such as leakage and reflux through that
segment. We can also avoid a thoracotomy in many patients,
so our choice has been to use long segments of colon for a
variety of theoretic reasons. I do think that, with proper
attention to detail, our results can be duplicated.
Dr. Claude Deschamps (Rochester, Minn.). Are you
concerned when you hook the colon on a little pouch of
distal stomach that you are going to get reflux, and did you
or your group consider doing a Roux-en-Y in those
patients instead of hooking to the distal antrum?
We also looked at our group of long-term survivors of
esophageal cancer, and we found that the minority of the
patients were asymptomatic, just like in your patients. Did
you look at dumping symptoms in those patients and how
they need medication in the long term?
Dr. Watson. Let me answer your second question first.
Yes, our questionnaire did concentrate on dumping symp-
toms. Many of the symptoms that patients experience
after an esophagectomy we believe are actually related to
the concomitant vagotomy and the alteration in gastroin-
testinal function that result; so our questionnaire did focus
on dumping, diarrhea, bloating, and such, and that is
reflected in our data.
With regard to your first question about anastomosing
the colon to the antrum, we believe that because of the
intraabdominal position of the antrum, reflux is not a
problem because the antrum is exposed to the positive-
pressure environment of the abdomen as is the distal
colonic segment. We think that forms somewhat of an
antireflux barricade. We have performed, for other indi-
cations, a colon graft to a Roux-en-Y segment in the
patient in whom the antrum had been previously resected.
We do worry in that situation, though, about Roux-stasis
syndrome and resultant dysphagia.
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Dr. Walter B. Cannon (Palo Alto, Calif.). Do you think
you have to resect the esophagus every time? There are
certainly situations where the esophagus is going to be
firmly adherent to the surrounding tissue, which might
lead to a rather difficult operation and perhaps unneces-
sary operation. Do you think that the esophagus should be
resected every time with these problems?
Dr. Watson. As compared to doing a bypass procedure?
Dr. Cannon. That’s right.
Dr. Watson. The only indication for which we have left
the native esophagus intact has been corrosive injuries,
where there has been a large amount of fibrosis within the
posterior mediastinum; I think that in such a situation, it
is reasonable to leave the native esophagus intact. There is
a theoretic concern for carcinoma appearing in the seg-
ment later, and the inability to access it for diagnosis; but
I do believe that would be rare.
Dr. John R. Benfield (Sacramento, Calif.). I have some
quarrel with the use of the word benign. The noncancerous
conditions you treated are anything but benign. Moreover,
those of us who have particular interest in cancer know
that there are certain cancers that really have a rather
benign behavior. Thus I think your paper would have been
just perfect had you deleted the word benign from the title
and simply called it end-stage esophageal disease.
In my experience with making anastomoses in the
neck, be it the stomach or the colon that is brought up,
I have found that the tight thoracic inlet is probably the
single most important factor that places the anastomo-
ses at risk. We have not actually tabulated this, but my
best estimate would be that, at least 30% of the time, I
end up resecting some of the manubrium or some
portion of the clavicle in the thoracic inlet to be sure
that there is no constriction. I wonder if your experi-
ence has been similar.
Dr. Watson. First of all with your comments about
benign disease, I am in absolute agreement that many of
these conditions are not benign as I showed in my slides
from Wales and Finland. So-called benign diseases have
certainly led to deaths, especially now with the increasing
prevalence of esophageal adenocarcinoma of which gas-
troesophageal reflux and Barrett’s are the only known risk
factors; it is certainly hard to consider that ongoing reflux
is completely a benign disease.
With regard to your question about the thoracic inlet,
we routinely resect the left hemimanubrium, head of the
first rib, and head of the clavicle when we bring up our
transposed organ in a substernal position, because we find
that, when they are substernal, those bony structures do
impede passage of food bolus. When we bring the organ
up through the posterior mediastinum, we have found that
to be less of a problem and have not had to resect those
bony structures in those circumstances. But again, we do it
routinely for the substernal route.
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